Targeting ATAD3A-PINK1-Mitophagy Axis Overcomes Chemoimmunotherapy Resistance by Redirecting PD-L1 to Mitochondria

By
Noshin Noorjahan
-
0
167
Scientists discovered that therapeutic response to immune checkpoint inhibitor plus paclitaxel was associated with subcellular redistribution of PD-L1.
[Cell Research]
Full Article